Arkolith/Insider Trading/MDGL/Form 4

Sibold William John

President and CEO, DirectorMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$718K
Net Open-Market Flow
-$718K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2026Sell(S)2K$431.94$718K162K
Mar 4, 2026Grant(A)15K—$0163K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Grant(A)19K—$019K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015769) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML